ClinicalTrials.gg
RecruitingNCT06771284Updated Jan 22, 2026

Problem Behavior Assessment and Intervention in IDEA Part C Services

An interventional study of Function-based assessment and intervention in Problem Behavior, Developmental Delay and Developmental Disability, sponsored by University of Nevada, Las Vegas. Recruiting at 1 site in United States. Open to participants aged 0 Months to 5 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-22.

Sponsored by University of Nevada, Las Vegas · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
0 Months to 5 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effect of function-based assessment and intervention to reduce problem behavior in children with developmental disability or delay in the context of IDEA Part C services. The investigators will conduct a single-case study to evaluate the efficacy of the intervention.

02

Conditions studied

  • Problem Behavior
  • Developmental Delay
  • Developmental Disability

Keywords

  • Early childhood
  • Problem behavior
  • Home-based services
  • IDEA Part C services
03

In context

Problem Behavior

178 studies on the registry are indexed under Problem Behavior; 47 are open to participants now.

This study's planned enrollment of 9 is below the median of 90 across 165 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

University of Nevada, Las Vegas is the lead sponsor of 75 studies on the registry; 22 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Months to 5 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Child Inclusion Criteria:

  • age birth to 5 years old
  • has a developmental disability or delay based on caregiver report and/or receiving early intervention services
  • has problem behavior, as reported by the caregiver and/or early intervention professional

Caregivers (e.g., parent, grandparent) of eligible child participants will participate with their child as the implementer of all procedures.

An early intervention professional will participate with each caregiver-child dyad to coach the caregiver, in addition to the researcher.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (estimated)

Study arms

  • Experimental
    Intervention

    Following baseline (i.e., no intervention/business as usual) sessions, children will receive the intervention, consisting of a function-based intervention. This intervention will be implemented by the caregiver. The intervention will consist of teaching the child an alternative, appropriate skill (usually communication) to replace the problem behavior. The caregiver will provide reinforcement for the appropriate skill and no reinforcement (i.e., extinction) following problem behavior. The caregiver will also learn and use general strategies for teaching social-emotional skills (e.g., setting appropriate rules) as part of the intervention.

    Behavioral: Function-based assessment and intervention

Interventions

  • BehavioralFunction-based assessment and intervention

    This intervention will be implemented by the caregiver. The intervention will consist of teaching the child an alternative, appropriate skill (usually communication) to replace the problem behavior. The caregiver will provide reinforcement for the appropriate skill and no reinforcement (i.e., extinction) following problem behavior. The caregiver will also learn and use general strategies for teaching social-emotional skills (e.g., setting appropriate rules) as part of the intervention.

06

What researchers measure

Primary outcomes

  1. Problem Behavior

    The investigators will conduct 5-min observations and record the frequency of the child's problem behavior (e.g., aggression, self-injury, screaming) during each session. The specific problem behavior(s) recorded will be defined individually by participant.

    Time frame: The investigators plan to conduct approximately weekly observations, with a total of 15 observations.

Secondary outcomes

  1. Appropriate Behavior

    The investigators will conduct 5-min observations and record the frequency of the child's appropriate behavior (e.g., communication) during each session. The specific appropriate behavior(s) recorded will be defined individually by child participant.

    Time frame: The investigators plan to conduct approximately weekly observations, with a total of 15 observations.

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06771284
Lead sponsor
University of Nevada, Las Vegas
Collaborators
Institute of Education Sciences
Responsible party
Stephanie Gerow (Associate Professor, University of Nevada, Las Vegas) — Principal investigator
First posted
Jan 13, 2025
Start date
Sep 30, 2025
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Jan 22, 2026

Study contacts

Stephanie Gerow, PhD
Contact
stephanie.gerow@unlv.edu
702-895-1109

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion